Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier

IF 8.3 1区 医学 Q1 CHEMISTRY, MEDICINAL
Mu-xia Li , Min-yao Li , Jun-xuan Lei , Yu-zhu Wu , Ze-hao Li , Lin-ming Chen , Chang-lin Zhou , Ji-yan Su , Guo-xin Huang , Xiao-qi Huang , Xue-bao Zheng
{"title":"Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier","authors":"Mu-xia Li ,&nbsp;Min-yao Li ,&nbsp;Jun-xuan Lei ,&nbsp;Yu-zhu Wu ,&nbsp;Ze-hao Li ,&nbsp;Lin-ming Chen ,&nbsp;Chang-lin Zhou ,&nbsp;Ji-yan Su ,&nbsp;Guo-xin Huang ,&nbsp;Xiao-qi Huang ,&nbsp;Xue-bao Zheng","doi":"10.1016/j.phymed.2022.154052","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The clinical treatment of ulcerative colitis (UC) is limited. A traditional Chinese medicinal formula, Huangqin decoction (HQD), is chronicled in <em>Shang Han Lun</em> and is widely used to ameliorate gastrointestinal disorders, such as UC; however, its mechanism is yet to be clarified.</p></div><div><h3>Purpose</h3><p>The present study aimed to investigate the effect of HQD on 7-day colitis induced by 3% dextran sulfate sodium (DSS) in mice and further explore the inhibitory effect of metabolites on DSS-damaged FHC cells.</p></div><div><h3>Methods</h3><p>The therapeutic efficacy of HQD was evaluated in a well-established DSS-induced colitis mice model. The clinical symptoms were analyzed, and biological samples were collected for microscopic examination, metabolomics, metagenomics, and the evaluation of the epithelial barrier function. The mechanism of metabolites regulated by HQD was evaluated in the DSS-induced FHC cell damage model. The samples were collected to detect the physiological functions of the cells.</p></div><div><h3>Results</h3><p>HQD suppressed the inflammation of DSS-induced colitis <em>in vivo</em>, attenuated DSS-induced clinical manifestations, reversed colon length reduction, and reduced histological injury. After HQD treatment, the DSS-induced gut dysbiosis was modulated, and the gut microbiota achieved a new equilibrium state. In addition, HQD activated the mTOR signaling pathway by upregulating amino acid metabolism. Significant phosphorylation of S6 and 4E-BP1 ameliorated intestinal epithelial barrier dysfunction. Moreover, HQD-regulated metabolites protected the epithelial barrier integrity by inhibiting DSS-induced apoptosis of FHC cells and regulating the proteins affecting apoptosis and cell-cell junction.</p></div><div><h3>Conclusions</h3><p>These findings indicated that the mechanism of HQD was related to regulating the gut microbiota and amino acid metabolism, activating the mTOR signaling pathway, and protecting the intestinal mucosal barrier integrity.</p></div>","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"100 ","pages":"Article 154052"},"PeriodicalIF":8.3000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"22","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0944711322001301","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 22

Abstract

Background

The clinical treatment of ulcerative colitis (UC) is limited. A traditional Chinese medicinal formula, Huangqin decoction (HQD), is chronicled in Shang Han Lun and is widely used to ameliorate gastrointestinal disorders, such as UC; however, its mechanism is yet to be clarified.

Purpose

The present study aimed to investigate the effect of HQD on 7-day colitis induced by 3% dextran sulfate sodium (DSS) in mice and further explore the inhibitory effect of metabolites on DSS-damaged FHC cells.

Methods

The therapeutic efficacy of HQD was evaluated in a well-established DSS-induced colitis mice model. The clinical symptoms were analyzed, and biological samples were collected for microscopic examination, metabolomics, metagenomics, and the evaluation of the epithelial barrier function. The mechanism of metabolites regulated by HQD was evaluated in the DSS-induced FHC cell damage model. The samples were collected to detect the physiological functions of the cells.

Results

HQD suppressed the inflammation of DSS-induced colitis in vivo, attenuated DSS-induced clinical manifestations, reversed colon length reduction, and reduced histological injury. After HQD treatment, the DSS-induced gut dysbiosis was modulated, and the gut microbiota achieved a new equilibrium state. In addition, HQD activated the mTOR signaling pathway by upregulating amino acid metabolism. Significant phosphorylation of S6 and 4E-BP1 ameliorated intestinal epithelial barrier dysfunction. Moreover, HQD-regulated metabolites protected the epithelial barrier integrity by inhibiting DSS-induced apoptosis of FHC cells and regulating the proteins affecting apoptosis and cell-cell junction.

Conclusions

These findings indicated that the mechanism of HQD was related to regulating the gut microbiota and amino acid metabolism, activating the mTOR signaling pathway, and protecting the intestinal mucosal barrier integrity.

黄芩汤改善dss诱导的溃疡性结肠炎:肠道菌群和氨基酸代谢、mTOR通路和肠上皮屏障的作用
背景溃疡性结肠炎(UC)的临床治疗是有限的。黄芩汤(HQD)是一种传统的中药配方,被记载在《商汉论》中,被广泛用于改善胃肠道疾病,如UC;然而,其机制尚不清楚。目的观察HQD对3%葡聚糖硫酸钠(DSS)致小鼠7 d结肠炎的影响,并进一步探讨代谢物对DSS损伤的FHC细胞的抑制作用。方法建立dss诱导结肠炎小鼠模型,观察HQD的治疗效果。对临床症状进行分析,并收集生物样本进行显微镜检查、代谢组学、宏基因组学和上皮屏障功能评估。在dss诱导的FHC细胞损伤模型中,评估了HQD调节代谢物的机制。采集样本检测细胞的生理功能。结果shqd在体内可抑制dss诱导结肠炎的炎症反应,减轻dss诱导的临床表现,逆转结肠长度缩短,减轻组织损伤。HQD处理后,dss诱导的肠道生态失调得到了调节,肠道菌群达到了新的平衡状态。此外,HQD通过上调氨基酸代谢激活mTOR信号通路。S6和4E-BP1显著磷酸化可改善肠上皮屏障功能障碍。此外,hqd调节的代谢物通过抑制dss诱导的FHC细胞凋亡和调节影响凋亡和细胞-细胞连接的蛋白来保护上皮屏障的完整性。结论HQD的作用机制可能与调节肠道菌群和氨基酸代谢,激活mTOR信号通路,保护肠黏膜屏障完整性有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Phytomedicine
Phytomedicine 医学-药学
CiteScore
10.30
自引率
5.10%
发文量
670
审稿时长
91 days
期刊介绍: Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信